Grant SM, Heel RC (1991) Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 41:889-926
Hancock EC, Osborne JP, Edwards SW (2008) Treatment of infantile spasms. Cochrane Database Syst Rev 4:CD001770
Hemming K, Maguire MJ, Hutton JL, Marson AG (2008) Vigabatrin for refractory partial epilepsy. Cochrane Database Syst Rev 3:CD007302
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291-366.
Horie Y, Kurachi Y. Glial inwardly rectifying potassium channels. In Y. Kurachi, L. Y. Jan & M. Lazdunski (Eds.), Potassium ion channels: molecular structure, function, and diseases. Current Topics in Membranes, vol 46, 1999, pp. 471-482, Academic Press, San Diego, CA, USA.
Hung TY, Chu FL, Wu DC, Wu SN, Huang CW (2019) The Protective Role of Peroxisome Proliferator-Activated Receptor-Gamma in Seizure and Neuronal Excitotoxicity. Mol Neurobiol 56:5497-5506
Jensen BS, Strøbaek D, Olesen SP, Christophersen P (2001) The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments? Curr Drug Targets 2:401-422
Kim DS, Kim JE, Kwak SE, Choi HC, Song HK, Kimg YI, Choi SY, Kang TC (2007) Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: a target of anti-epileptic drugs. Brain Res 1185:346-358
Koekkoek JA, Dirven L, Heimans JJ, Postma TJ, Vos MJ, Reijneveld JC, Taphoorn MJ (2015) Seizure reduction in a low-grade glioma: More than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry 86:366-373
Lai MC, Tzeng RC, Huang CW, Wu S N (2019) The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents. Biomolecules 9:E638
Lallet-Daher H, Roudbaraki M, Bavencoffe A, Mariot P, Gackiere F, Bidaux G, Urbain R, Gosset P, Delcourt P, Fleurisse L, Slomianny C, Dewailly E, Mauroy B, Bonnal JL, Skryma R, Prevarskaya N (2009) Intermediate-conductance ca2+-activated k+ channels (ikca1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28:1792-1806
Leanza L, O'Reilly P, Doyle A, Venturini E, Zoratti M, Szegezdi E, Szabo I (2014) Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines. Curr Pharm Des 20:189-200
Lee CY, Lai HY, Chiu A, Chan SH, Hsiao LP, Lee ST (2016) The effects of antiepileptic drugs on the growth of glioblastoma cell lines. J Neurooncol 127: 445-453
Liang Z, Chen L, McClafferty H, Lukowski R, MacGregor D, King JT, Rizzi S, Sausbier M, McCobb DP, Knaus HG, Ruth P, Shipston MJ (2011) Control of hypothalamic-pituitary-adrenal stress axis activity by the intermediate conductance calcium-activated potassium channel, SK4. J Physiol 589:5965-5986
Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP (2004) The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 364:1773-1778
McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H (2012) Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am J Physiol Cell Physiol 303:C1070-1078
McMillin GA, Krasowski MD (2016) Therapeutic Drug Monitoring of Newer Antiepileptic Drugs. In Clinical Challenges in Therapeutic Drug Monitoring.
Mohr CJ, Gross D, Sezgin EC, Steudel FA, Ruth O. Huber SM, Lukowski R (2019a) KCa 3.1 channels confer radioresistance to breast cancer cells. Cancers (Basel) 11:1285
Mohr CJ, Steudel FA, Gross D, Ruth P, Lo WY, Hoppe R, Schroth W, Brauch H, Huber SM, Lukowski R (2019b) Cancer-associated intermediate conductance ca(2+)-activated k⁺ channel k(ca)3.1. Cancers (Basel) 11:109
Ohya S, Niwa S, Kojima Y, Sasaki S, Sakuragi M, Kohri K, Imaizumi Y (2011) Intermediate-conductance Ca2+- activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia. J Pharmacol Exp Ther 338:528-536
Roozekrans M, van der Schrier R, Okkerse P, Hay J, McLeod JF, Dahan A (2014) Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers. Anesthesiology 121:459-468
Schechter PJ (1989) Clinical pharmacology of vigabatrin. Br J Clin Pharmacol 27(Suppl 1):19-22
Schnepp PM, Lee DD, Guldner IH, O'Tighearnaigh TK, Howe EN, Palakurthi B, Eckert KE, Toni TA, Ashfeld BL, Zhang S (2017) GAD1 upregulation programs aggressive features of cancer cell metabolism in the brain metastatic microenvironment. Cancer Res 77:2844-2856
Schwab A, Fabian A, Hanley PJ, Stock C (2012) Role of ion channels and transporters in cell migration. Physiol Rev 92:1865-1913
Silverman RB (2004) The organic chemistry of drug design and drug action. 2nd Edition. Elsevier. Chapter 5. Enzyme inhibition and inactivation. PP.290
Steinle M, Palme D, Misovic M, Rudner J, Dittmann K, Lukowski R, Ruth P, Huber SM (2011) Ionizing radiation induces migration of glioblastoma cells by activating BK K(+) channels. Radiother Oncol 101:122-126
Turner RW, Kruskic M, Teves M, Scheidl-Yee T, Hameed S, Zamponi GW (2015) Neuronal expression of the intermediate conductance calcium-activated potassium channel kca3.1 in the mammalian central nervous system. Pflugers Arch 467:311-328
Wang CL, Tsai ML, Wu SN (2013) Evidence for mitoxantrone-induced block of inwardly rectifying K+ channels expressed in the osteoclast precursor RAW 264.7 cells differentiated with lipopolysaccharide. Cell Physiol Biochem 30:687-701
Wu SN, Peng H, Chen BS, Wang YJ, Wu PY, Lin MW (2008) Potent activation of large-conductance ca2+-activated k+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (ns1643) in pituitary tumor (gh3) cells. Mol Pharmacol 74:1696-1704
Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V (2007) Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14:1437-1457
Yeh PS, Wu SJ, Hung TY, Huang YM, Hsu CW, Sze CI, Hsieh YJ, Huang CW, Wu SN (2016) Evidence for the Inhibition by temozolomide, an imidazotetrazine family alkylator, of intermediate-conductance Ca2+-activated K+ channels in glioma cells. Cell Physiol Biochem 38:1727-1742
Zonouzi M, Scafidi J, Li P, McEllin B, Edwards J, Dupree JL, Harvey L, Sun D, Hübner CA, Cull-Candy SG, Farrant M, Gallo V (2015) GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury. Nat Neurosci 18:674-682